Atlas ArteriaMAQAF 77 14-Day RSI is 58.68 as of Jul. 09, 2026. GuruFocus rates MAQAF with a GF Score™ of 77/100 and a GF Value™ of $4.20 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,886 Construction companies, Atlas Arteria ranks better than 51.48% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-09), Atlas Arteria's 14-Day RSI is 58.68.
The industry rank for Atlas Arteria's 14-Day RSI or its related term are showing as below:
MAQAF's 14-Day RSI is ranked better than 51.48% of 1886
companies
in the Construction industry
Industry Median: 45.35
vs MAQAF: 58.68
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Atlas Arteria 14-Day RSI Related Terms
Atlas Arteria 14-Day RSI Competitor Comparison
For the Infrastructure Operations subindustry, Atlas Arteria's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atlas Arteria 14-Day RSI vs Construction Industry
For the Construction industry and Industrials sector, Atlas Arteria's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Atlas Arteria's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atlas Arteria (MAQAF) has a 14-Day RSI of 58.68 as of Jul. 09, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Atlas Arteria and its competitors. According to the industry distribution chart, Atlas Arteria ranks #915 out of 1886 companies in the Construction industry, placing it in the top 48.5%.
Is Atlas Arteria's 14-Day RSI too high?
Atlas Arteria's current 14-Day RSI is 58.68. The Construction industry median 14-Day RSI is 45.35. Atlas Arteria's value of 58.68 is 29.4% above this industry median. Based on the distribution chart, Atlas Arteria ranks #915 out of 1886 companies in the Construction industry, which is above the industry midpoint. Overall, Atlas Arteria has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's 14-Day RSI compare to competitors?
According to the Construction industry distribution chart, Atlas Arteria ranks #915 out of 1886 companies for 14-Day RSI. This puts Atlas Arteria in the upper half of its industry. The industry median 14-Day RSI is 45.35. Atlas Arteria's value of 58.68 is 29.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Construction company?
The median 14-Day RSI among Construction companies is 45.35, based on 1,886 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atlas Arteria's current 14-Day RSI of 58.68 is 29.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Atlas Arteria and its competitors. For the Construction industry, the median 14-Day RSI is 45.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atlas Arteria's current 14-Day RSI is 58.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (MAQAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.20, compared to a current price of $3.55 — trading 15.5% below its estimated fair value. The current 14-Day RSI is 58.68 and 29.4% above the Construction industry median of 45.35. Atlas Arteria's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Atlas Arteria (MAQAF), the current 14-Day RSI is 58.68 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Atlas Arteria (MAQAF) Overvalued in 2026?
Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued.
The current stock price of $3.55 is trading 15.5% below its estimated GF Value™ of $4.20.
GuruFocus considers Atlas Arteria to be Modestly Undervalued.
Key valuation signals for MAQAF:
14-Day RSI: 58.68
GF Value™: $4.20 vs. price of $3.55 (15.5% below fair value)
Industry Position: 29.4% above the Construction median (#915 of 1886)
No single metric tells the full story. See the MAQAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
77GF Score
Get the complete analysis for MAQAF
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAQAF has been successfully added to your 